Circulation, Vol 71, 434-440, Copyright © 1985 by American Heart Association
L Roy, HR Knapp, RM Robertson and GA FitzGerald
The potent platelet inhibitory and vasodilator properties of prostacyclin
suggest that levels of this substance may be of relevance to drug action
and pathologic processes in the coronary vascular bed. Attempts to estimate
the coronary secretion rate of prostacyclin have relied on measurements of
metabolites obtained via cardiac catheter, usually as an adjunct to
coronary angiography. To test the hypothesis that such procedures might
themselves perturb endogenous biosynthesis of prostacyclin we used mass
spectrometry to measure plasma levels of 6- keto-prostaglandin (PG) F1
alpha across the coronary vascular bed, as well as to assess the excretion
of a major urinary metabolite, 2,3- dinor-6-keto-PGF1 alpha (PGI-M), in
patients undergoing cardiac catheterization. PGI-M excretion increased
variably from a median 100 to 205 pg/mg creatinine (p less than .01) during
catheterization with angiography and remained elevated 2 to 4 hr after
initiation of the procedure. However, cardiac catheterization without
angiography also stimulated metabolite excretion, perhaps reflecting
catheter-induced vascular trauma. The direct effect of radiocontrast media
on vascular release of prostacyclin was indicated by increased PGI-M
excretion in healthy volunteers administered intravenous radiocontrast and
by studies of the canine coronary artery and jugular vein in vitro.
Measurement of plasma 6-keto-PGF1 alpha after left heart catheterization
showed that levels in aortic (21 +/- 8 pg/ml) and coronary sinus (14 +/- 2
pg/ml) blood were increased compared with peripheral venous levels (less
than or equal to 4 + 1 pg/ml) determined before this procedure.(ABSTRACT
TRUNCATED AT 250 WORDS)
ARTICLES
Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man
This article has been cited by other articles:
![]() |
Y. Cheng, S. C. Austin, B. Rocca, B. H. Koller, T. M. Coffman, T. Grosser, J. A. Lawson, and G. A. FitzGerald Role of Prostacyclin in the Cardiovascular Response to Thromboxane A2 Science, April 19, 2002; 296(5567): 539 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pratico, Y. Cheng, and G. A. FitzGerald TP or Not TP: Primary Mediators in a Close Runoff? Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1695 - 1698. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |